Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 3077-3086

  Rafi, Asimah Q ^a   Zeytun, Ahmet ^a   Bradley, Michael J ^a   Sponenberg, D Phillip ^a   Grayson, Randolph L ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a,b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; HERMES ANTIGEN; INTERLEUKIN 2; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY LEAK SYNDROME; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; KNOCKOUT MOUSE; LIVER; LUNG ENDOTHELIUM; LYMPHOCYTE MIGRATION; LYMPHOKINE ACTIVATED KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD95; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FAS LIGAND PROTEIN; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LIGANDS; LIVER; LUNG; LYMPHOCYTE COUNT; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; PORE FORMING CYTOTOXIC PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032531087     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. + T cells. Immunol. Today 11:55.
2. Tsukada, N., M. Matsuda, K. Miyagi, and N. Yanagisawa. 1993. Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis. J. Neurol. Sci. 117:140.
3. Moyer, C. F., and C. L. Reinisch. 1983. The role of vascular smooth muscle cells in experimental autoimmune vasculitis. Am. J. Pathol. 117:380.
4. McCluskey, R. T., and R. Feinberg. 1983. Vasculitis in primary vasculitides, granulomatoses, and connective tissue diseases. Hum. Pathol. 14:305.
5. Hewicker, M., and G. Trautwein. 1987. Sequential study of vasculitis in MRL mice. Lab. Anim. 21:335.
6. Fox, W. M., A. Hameed, G. M. Hutchins, B. A. Reitz, W. A. Baumgartner, W. E. Beschorner, and R. H. Hruban. 1993. Perform expression localizing cytotoxic lymphocytes in the intimas of coronary arteries with transplant-related accelerated arteriosclerois. Hum. Pathol. 24:477.
7. van der Wal, A. C., P. K. Das, A. J. Tigges, and A. E. Becker. 1992. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am. J. Pathol. 141:1427.
8. Bechard, D. E., S. A. Gudas, M. M. Sholley, A. J. Grant, R. E. Merchant, R. P. Fairman, A. A. Fowler, and F. L. Glauser. 1989. Nonspecific cytotoxicity of recombinant interleukin-2 activated lymphocytes. Am. J. Med. Sci. 298:28.
9. Vial, T., and J. Descotes. 1995. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug. Saf. 13:371.
10. Damle, N., L. Doyle, J. Bender, and E. Bradley. 1987. Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J. Immunol. 138:1779.
11. Damle, N., and L. Doyle. 1989. IL-2 activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. J. Immunol 142:2660.
12. Ward, P. A. 1996. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann. NY Acad. Sci. 796:104.
13. Hammond-McKibben, D., A. Seth, P. Nagarkatti, and M. Nagarkatti. 1995. Characterization of factors regulating successful immunotherapy using a tumor-specific cytotoxic T lymphocyte clone: role of interleukin-2, cycling pattern of lytic activity and adhesion molecules Int. J. Cancer 60:828.
14. Kagi, D., F. Vignaux, B. Lederman, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
15. Walsch, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
16. Hammond-Mckibben, D., A. Rafi, M. Nagarkatti, and P. S. Nagarkatti. 1996. Fas and FasL interactions in cytotoxicity and its role in lymphoproliferative disease. In Molecular Biology of Hematopoiesis, Vol. 5. N. G. Abraham, ed. Plenum Press, New York, p. 411.
17. Seth, A., L. Gote, M. Nagarkatti, and P. S. Nagarkatti. 1991. T-cell receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90 MEL-14. Proc. Natl. Acad. Sci. USA 88:7877.
18. Rosenstein, M., S. Ettinghausen, and S. Rosenberg. 1986. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J. Immunol. 137:1735.
19. Li, L., J. Elliott, and T. Mossmann. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153:3967.
20. Hammond, D., P. S. Nagarkatti, L. Gote, A. Seth, M. Hassuneh, and M. Nagarkatti. 1993. Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perform gene. J. Exp. Med. 178:2225.
21. Galandrini, R., N. Albi, G. Tripodi, D. Zarcone, A. Terenzi, A. Moretta, C. E. Grossi, and A. Velardi. 1993. Antibodies to CD44 trigger effector functions of human T cells clones. J. Immunol. 150:4225.
22. Tan, P. H., E. B. Santos, H. C. Rossbach, and B. M. Sandmaier. 1993. Enhancement of natural killer activity by an antibody to CD44. J. Immunol. 150:812.
23. Rosenberg, S., M. T. Lotze, L. M. Muul, S. Leitman, A. E. Chang, S. E. Ettinghausen, Y. L. Matory, J. M. Skibber, E. Shiloni, J. T. Vetto, et al. 1985. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313:1485.
24. Lotze, M. T., Y. L. Matory, A. A. Rayner, S. E. Ettinghausen, J. T. Vetto, C. A. Seipp, and S. A. Rosenberg. 1986. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer 58:2764.
25. Maling, H. M., M. E. Webster, W. A. Williams, W. Saul, and W. Anderson. 1973. Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: antagonists and mechanisms of action. J. Pharmacol. Exp. Ther. 191: 300.
26. Willoughby, D. A. 1973. Mediation of increased vascular permeability in inflammation. In The Inflammatory Process, 2nd Ed., Vol. 2. B. W. Zwenfach, L. Grant, and R. T. McCluskey, eds. Academic Press, New York, p. 303.
27. Sobel, A., and G. Lagrue. 1980. Role of vascular permeability-increasing factor released by lymphocytes in renal pathology. In Lymphokine Reports, Vol. 1. E. Pick, ed. Academic Press, New York, p. 211.
28. Damle, N. K., and L. V. Doyle. 1987. Interleukin-2 activated human killer lymphocytes: lack of involvement of interferon in the development of IL-2 activated killer lymphocytes. Int. J. Cancer 40:519.
29. Peace, D. J., and M. A. Cheever. 1989. Toxicity and therapeutic efficacy of high-dose interleukin 2. J. Exp. Med. 169:161.
30. Quinn DeJoy, S., R. Jeyasellan, L. Torley, S. Schow, M. Wick, and S. Serwar. 1995. Attenuation of interleukin 2-induced pulmonary vascular leak syndrome by low doses of oral methotrexate. Cancer Res. 55:4929.
31. Ohkobo, C., D. Bigos, and R. Jain. 1991. Interleukin 2 inducted leukocyte adhesion to the normal and tumor a microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. Cancer Res. 51:1561.
32. Dubinett, S. M., M. Huang, A. Lichtenstein, W. H. McBride, J. Wang, G. Markovitz, D. Kelley, W. W. Grody, L. E. Mintz, and S. Dhanani. 1994. Tumor necrosis factor-α plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation. Cell. Immunol. 157:170.
33. Quinn, T. D., F. N. Miller, M. A. Wilson, R. N. Garrison, J. A. Anderson, L. G. Lenz, and M. J. Edwards. 1990. Interleukin-2-induced lymphocyte infiltration of multiple organs is differentially suppressed by soluble tumor necrosis factor receptor. J. Surg. Res. 56:117.
34. Thijs, L. G., C. E. Hack, R. J. Strack van Schijndel, J. H. Nuijens, G. J. Wolbink, A. J. Eerenberg-Belmer, H. Van der Vall, and J. Wagstaff. 1990. Activation of the complement system during immunotherapy with recombinant IL-2. J. Immunol. 144:2419.
35. Rabinovici, R., M. D. Sofronski, P. Borboroglu, A. M. Spirig, L. M. Hillegas, J. Levine, J. Vernick, S. M. Scesney, N. Feuerstein, and G. Feruerstein. 1994. Interleukin-2-induced lung injury. Circ. Res. 74:329.
36. 36: Harlan, J. M., P. D. Killen, L. A. Harker, G. E. Striker, and D. G. Wright. 1981. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J. Clin. Invest. 68:1394.
37. Martin, W. J. 1984. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. Am. Rev. Respir. Dis. 103:209.
38. Diener, A. M., P. G. Beatty, H. D. Ochs, and J. M. Harlan. 1985. The role of neutrophil membrane glycoprotein 150 (Gp-150) in neutrophil-mediated endothelial cell injury in vitro. J. Immunol. 135:537.
39. Anderson, T. D., T. J. Hayes, M. K. Gately, J. M. Bontempo, L. L. Stern, and G. A. Truitt. 1985. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Lab. Invest. 59:598.
40. Fujita, S., R. Puri, Z. Yu, W. Travis, M. Yamaguchi, and V. Ferrans. 1994. Interleukin-1α reduces the severity of the vascular leak syndrome produced by interleukin-2 and interleukin-2 plus interferon-α. Toxicol. Pathol. 22:381.
41. Kakkanaiah, V. N., R. H. Pyle, M. Nagarkatti, and P. S. Nagarkatti. 1990. Evidence for major alterations in the thymocyte subpopulations in murine models of autoimmune diseases. J. Autoimmun. 3:271.
42. Sconocchia, G., J. A. Titus, and D. M. Segal. 1994. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J. Immunol. 153:5473.